Eurobio-Scientific SA (FR:ALERS)
:ALERS
Want to see FR:ALERS full AI Analyst Report?
Total Valuation
Eurobio-Scientific SA has a market cap or net worth of €226.12M. The enterprise value is €223.24M.
Market Cap€226.12M
Enterprise Value€223.24M
Share Statistics
Eurobio-Scientific SA has 10,248,871 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10,248,871
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Eurobio-Scientific SA’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 3.16%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)3.16%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee513.68K
Profits Per Employee14.79K
Employee Count329
Asset Turnover0.66
Inventory Turnover3.51
Valuation Ratios
The current PE Ratio of Eurobio-Scientific SA is 50.9. Eurobio-Scientific SA’s PEG ratio is 2.21.
PE Ratio50.9
PS Ratio1.48
PB Ratio1.36
Price to Fair Value1.36
Price to FCF39.72
Price to Operating Cash Flow18.37
PEG Ratio2.21
Income Statement
In the last 12 months, Eurobio-Scientific SA had revenue of 169.00M and earned 4.90M in profits. Earnings per share was 0.48.
Revenue169.00M
Gross Profit68.40M
Operating Income10.80M
Pretax Income7.80M
Net Income4.90M
EBITDA19.70M
Earnings Per Share (EPS)0.48
Cash Flow
In the last 12 months, operating cash flow was 12.82M and capital expenditures -11.07M, giving a free cash flow of 1.75M billion.
Operating Cash Flow12.82M
Free Cash Flow1.75M
Free Cash Flow per Share0.17
Dividends & Yields
Eurobio-Scientific SA pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.21
52-Week Price Change-10.67%
50-Day Moving Average22.69
200-Day Moving Average24.05
Relative Strength Index (RSI)40.48
Average Volume (3m)968.00
Important Dates
Eurobio-Scientific SA upcoming earnings date is Oct 13, 2026, Before Open (Confirmed).
Last Earnings DateApr 10, 2026
Next Earnings DateOct 13, 2026
Ex-Dividend Date―
Financial Position
Eurobio-Scientific SA as a current ratio of 1.98, with Debt / Equity ratio of 8.71%
Current Ratio1.98
Quick Ratio1.36
Debt to Market Cap0.04
Net Debt to EBITDA-0.22
Interest Coverage Ratio3.72
Taxes
In the past 12 months, Eurobio-Scientific SA has paid 2.90M in taxes.
Income Tax2.90M
Effective Tax Rate0.37
Enterprise Valuation
Eurobio-Scientific SA EV to EBITDA ratio is 12.45, with an EV/FCF ratio of 39.04.
EV to Sales1.45
EV to EBITDA12.45
EV to Free Cash Flow39.04
EV to Operating Cash Flow13.01
Balance Sheet
Eurobio-Scientific SA has €20.66M in cash and marketable securities with €16.02M in debt, giving a net cash position of €4.65M billion.
Cash & Marketable Securities€20.66M
Total Debt€16.02M
Net Cash€4.65M
Net Cash Per Share€0.45
Tangible Book Value Per Share€3.16
Margins
Gross margin is 44.71%, with operating margin of 6.39%, and net profit margin of 2.90%.
Gross Margin44.71%
Operating Margin6.39%
Pretax Margin4.62%
Net Profit Margin2.90%
EBITDA Margin11.66%
EBIT Margin6.39%
Analyst Forecast
The average price target for Eurobio-Scientific SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast9.08%
EPS Growth Forecast21.19%